[Gastroduodenal hemorrhages of peptic origin and the outlook for using somatostatin (Stilamin)].
Smakov
G M
GM
D002986:Clinical Trials as Topic; D000075202:Contraindications; D004381:Duodenal Ulcer / Q000150:complications* / Q000188:drug therapy; D006490:Hemostatics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy*; D013004:Somatostatin / Q000494:pharmacology / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000150:complications* / Q000188:drug therapy
D006490:Hemostatics; D013004:Somatostatin
Gastroduodenal'nye krovotecheniia iazvennogo geneza i perspektivy isol'zovaniia somatostatina (stilamina).